Back to trial detailsIntake questionnaire
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Applying to Temple Heart and Vascular Institute (Outpatient Clinic) · Philadelphia, Pennsylvania
Answer a few short questions to share with the research team.
0 of 4 answered